#DYN — FinScans

News 📈 Stocks

Novartis Shares Plunge 11% After $32 Billion Market Value Wipeout

September 19, 2026 (52 days ago)

Novartis stock plummeted 10.9% following the failure of its del-desiran trial, triggering a sector-wide selloff in muscular-disease stocks including Sarepta and Dyne…

NVS SRPT DYN

🌍 EUROPE Read More →

News 📈 Stocks

Dow Futures Slip 366 Points as Amgen Slump Weighs on Price-Weighted Index

September 10, 2026 (61 days ago)

Amgen's 6% premarket decline drags the Dow Jones lower, while Novartis trial failures trigger a broader sell-off in related biotech stocks including…

AMGN DJIA

🌍 NORTH AMER Read More →

News 🏛 Indices

Dyne Therapeutics Shares Plunge 31% in Premarket Trading

September 8, 2026 (63 days ago)

Dyne Therapeutics shares fell 31% in premarket trading on no confirmed news, decoupling from the broader market as investors await further updates…

DJI ^GSPC NDX

🌍 NORTH AMER Read More →